|
Thursday 21st November 2019 |
Text too small? |
Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30. While growth...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/aft-pharmaceuticals-starts-to-hit-its-straps
No comments yet
CEN - Contact31+ Strategy, Capital Markets Day 2025
November 25th Morning Report
RYM - Successful completion of full bank debt refinance
Curious about dividend investment strategies?
Kiwi Property delivering on FY26 strategic priorities
Genesis Approves Investment for Edgecumbe Solar Farm
November 24th Morning Report
General Capital Announces Further Strong Growth
Comvita announces key leadership appointments
OCA - Momentum Building on Stronger Foundations